Navigation Links
Journal of Biological Chemistry Changes Approach to Manuscript Reviews and Eliminates Submission Fees
Date:1/14/2010

Editors say the new mission statement and shift in editorial criteria are in response to changing nature of biological research

BETHESDA, Md., Jan. 14 /PRNewswire-USNewswire/ -- The Journal of Biological Chemistry's editors are unveiling this week a number of changes to the journal's publishing policies. They say the changes are in response to the increasingly interdisciplinary nature of biological research and will help the journal better meet the evolving needs of the scientific community.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100114/DC37802 )

In an editorial in this week's issue of the JBC, which became available online Friday, the editors announced the journal's new mission statement and laid out changes to how manuscripts are judged by peer review. They also reported that the journal's submission fees have been eliminated to expedite the submission process and hold down costs to authors.

"These developments represent a commitment to publishing the very best science in the JBC," said Dr. Herbert Tabor, the journal's longtime editor-in-chief. "Our new mission statement reflects our understanding that molecular and cellular biology studies are being carried out in a variety of fields, and modifying how our reviewers approach manuscripts will better serve both readers and authors."

When the JBC was established in 1905, its founders set out to publish "anything of a chemical nature in the whole field of biology, whether this touches the plant or animal kingdom." In the decades since, the journal has embraced papers that provide clear "mechanistic insight" into any molecular process, which is to say it accepted papers that not only reported that a molecular process occurred but how or why it occurred.

Now, JBC editors are broadening their definition of "mechanism," in light of path-breaking research being done in new, still-developing fields that, while molecular in the level of analysis, has not yet reached the stage at which it provides the level of detailed mechanistic information expected in more established research areas.

"The fields have evolved so much that you can't always understand mechanistic details fully at the outset," explained JBC Deputy Editor Robert D. Simoni. "We recognize that you cannot in a single paper solve a problem entirely. But, if you develop novel insights into the molecular nature of biological processes that are clear, interesting and important -- and that open the door for answering the next generation of questions -- your paper belongs in the JBC."

In the January issue of ASBMB Today, the member magazine of the American Society for Biochemistry and Molecular Biology, which publishes the JBC and two other journals, Simoni wrote that "a great number of exciting molecular and cellular biology studies are being carried out in neuroscience, developmental biology, cell biology, medical science, biophysics, immunology, microbiology, physiology, etc. We wish to emphasize that … much of the research in these areas would be very welcome in the JBC."

The "modest course adjustment," he said, also will affect how the journal categorizes manuscripts.

The journal's table of contents will reflect all areas of biology that can be studied at a molecular level. In addition, articles may appear under more than one category, which Simoni said will make finding relevant articles easier for readers and will increase authors' visibility.

To find out more about the Journal of Biological Chemistry, visit www.jbc.org. To read the JBC editorial, visit www.jbc.org/site/home/editorials/toc_changes.xhtml .  To read Simoni's article in ASBMB Today, visit www.asbmb.org/asbmbtoday/asbmbtoday_article.aspx?id=4940.

About the American Society for Biochemistry and Molecular Biology

The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Most members teach and conduct research at colleges and universities. Others conduct research in various government laboratories, at nonprofit research institutions and in industry. The Society's student members attend undergraduate or graduate institutions.  For more information about ASBMB, visit www.asbmb.org.

SOURCE American Society for Biochemistry and Molecular Biology

RELATED LINKS
http://www.asbmb.org

'/>"/>

SOURCE American Society for Biochemistry and Molecular Biology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott Wins Top Honor in Wall Street Journal Technology Innovation Awards
2. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) is Feasible in Patients Requiring Undeferrable Non-Cardiac Surgery, International Journal of Cardiology Publication Reports
3. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
4. Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
5. Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine
6. New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
7. Statement From Michael Hansen, CEO of Elseviers Health Sciences Division, Regarding Australia Based Sponsored Journal Practices Between 2000 and 2005
8. Life sticks: UC San Diego bioengineers sticky insights published in journal Science
9. The Journal of Cardiac Failure Publishes Results From Celladon Corporations First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
10. Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth
11. NanoLogix Adds Noted Journalist Bill Scanlon to Provide Media Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 22, 2017 , ... Pharma and biotech consulting firm ... Operating from Pennside’s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 years ... than a decade with leading market research firm, GfK. He began his pharma ...
(Date:2/22/2017)... Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 ... ) today announced its financial results for the ... "Our annual 2016 financial results reflect continued ... earnings exceeded $700 million," said Martine Rothblatt, Ph.D., ... financial results strengthen our ability to develop and ...
(Date:2/21/2017)... , Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... and operational results for the three months ended December 31, ... -based life sciences and diagnostics company that develops and ... ... continue to build on the commercial milestones achieved in fiscal ...
(Date:2/21/2017)... ... February 21, 2017 , ... Vortex Biosciences announced ... automated benchtop system for collecting intact circulating tumor cells (CTCs) that are shed ... Medicine Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , The ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):